Beyond immune cell-mediated liver injury, hepatocytes in patients with non-alcoholic fatty liver disease (NAFLD) and alcoholic steatohepatitis can directly activate the NLRP3-caspase-1 or DAG-PKCδ-NLRC4 inflammasomes, inducing pyroptosis. Here, PRKCD is linked to metabolic dysfunction-associated steatotic liver disease.